More on switching statins: Comments from PfizerBMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7569.655 (Published 21 September 2006) Cite this as: BMJ 2006;333:655
- Kate Lloyd, medical director (Kate.Lloyd@Pfizer.com)
- Pfizer, Tadworth, Surrey KT20 7NS
EDITOR—Moon and Bogle claim that all statins are the same except for the cost.1 NHS costs need to be managed but should not be the sole driver of clinical decision making.
New guidelines recommend that cholesterol < 4 mmol/l is the optimal target for patients with cardiovascular disease, diabetes, or high risk primary prevention.2 Data modelled from the CURVES …